Innovation & Entrepreneurship

Normal-Web-Banner-Innovation

The Office of Innovation and Enterprise (OIE) was set up in June 2022 to establish programmes promoting innovation and entrepreneurship at LKCMedicine via initiatives to support faculty in their efforts towards translational research. The office was under the guidance of Professor Lim Kah Leong in 2022 till Associate Professor Kevin Pethe took on the role of Assistant Dean of Innovation and Enterprise from April 2023 to March 2025. Associate Professor Andrew Tan has been appointed as the Vice Dean of Innovation and Enterprise effective April 2025.

OIE strives to cultivate a dynamic ecosystem for innovation within LKCMedicine, where aspiring innovators are recognized and empowered to turn ideas into impactful solutions. Acting as a catalyst for innovation, OIE bridges the gap between research and translation of research.

The Office of Innovation and Enterprise (OIE) transforms ideas into real-world impact by:

  • Increasing the development of commercialisable intellectual property within LKCMedicine
  • Supporting the creation of startups and fostering collaborations with industrial partners
  • Driving innovation and entrepreneurship through dedicated programs and initiatives

OIE also offers support in IP and project strategy development, project management, market analysis and more within the Biotech and Medtech sectors. Additionally, OIE connects faculty with academic and industry stakeholders, fostering collaboration and partnerships to drive translational opportunities.